Correlation Between CellaVision and Biotage AB

Can any of the company-specific risk be diversified away by investing in both CellaVision and Biotage AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CellaVision and Biotage AB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CellaVision AB and Biotage AB, you can compare the effects of market volatilities on CellaVision and Biotage AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CellaVision with a short position of Biotage AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of CellaVision and Biotage AB.

Diversification Opportunities for CellaVision and Biotage AB

0.71

Correlation Coefficient

CellaVision  Biotage AB

Poor diversification

The 3 months correlation between CellaVision and Biotage is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding CellaVision AB and Biotage AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotage AB and CellaVision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CellaVision AB are associated (or correlated) with Biotage AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotage AB has no effect on the direction of CellaVision i.e., CellaVision and Biotage AB go up and down completely randomly.

Pair Corralation between CellaVision and Biotage AB

Assuming the 90 days trading horizon CellaVision AB is expected to generate 15.12 times more return on investment than Biotage AB. However, CellaVision is 15.12 times more volatile than Biotage AB. It trades about 0.06 of its potential returns per unit of risk. Biotage AB is currently generating about 0.17 per unit of risk. If you would invest  16,293  in CellaVision AB on April 24, 2025 and sell it today you would earn a total of  1,487  from holding CellaVision AB or generate 9.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.36%
Values	Daily Returns

CellaVision AB  vs.  Biotage AB

CellaVision AB

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CellaVision AB are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CellaVision may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Biotage AB

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Biotage AB are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Biotage AB is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with CellaVision and Biotage AB

The main advantage of trading using opposite CellaVision and Biotage AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CellaVision position performs unexpectedly, Biotage AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotage AB will offset losses from the drop in Biotage AB's long position.

The idea behind CellaVision AB and Biotage AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.